Established new compound IMB16-4 self-emulsifying drug delivery systems for increasing oral bioavailability and enhancing anti-hepatic fibrosis effect.

Niu, Xia; Meng, Yanan; Wang, Yucheng; Li, Guiling

Established new compound IMB16-4 self-emulsifying drug delivery systems for increasing oral bioavailability and enhancing anti-hepatic fibrosis effect.

Niu, Xia; Meng, Yanan; Wang, Yucheng; Li, Guiling.

Afiliação

Niu X; Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China.
Meng Y; Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China.
Wang Y; Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China. Electronic address: wangyucheng@imb.pumc.edu.cn.
Li G; Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China. Electronic address: liguiling@imb.pumc.edu.cn.

Biomed Pharmacother ; 154: 113657, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36942601

Assuntos

Sistemas de Liberação de Medicamentos; Ratos; Animais; Emulsões; Disponibilidade Biológica; Sistemas de Liberação de Medicamentos/métodos; Solubilidade; Fibrose; Administração Oral

Palavras-chave

Anti-liver fibrosis; Dissolution rate; IMB16-4 self-emulsifying drug delivery systems; Liver fibrosis; No specific therapy; Oral bioavailability; Seeking for effective drugs; TGFß1

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos Limite: Animals Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: França

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google